Replies to post #133 on Aida Pharmaceuticals (AIDA)

[PaperProphet]

The stock took a massive hit when they filed the 8-K with the SEC in April regarding the $7M. It looks like it got another $0.25 hit to the share price based on the quarterly report. I don't see anything else adverse in the 10-Q that wasn't there last time.